In PTEN-positive prostate and breast cancer cells, loss of α6- or β4-integrin expression caused a strong reduction in the other heterodimer partner and plectin, while in PTEN-negative cells both the protein levels of the heterodimer partner and plectin were only modestly affected or even upregulated. This evidence concerns the gene PLEC and breast carcinoma.